ADRB2 and breast carcinoma: Therefore, the aim of this study was to explore, through a combination of bioinformatic intracellular pathway analysis (BIPA) and molecular docking simulations, the binding affinity of various nsBBs for three receptors associated with breast cancer: ADRB2, ERBB2, and NPYR.